Conversely, others have reported that CPT1 expression is elevated in triple-negative breast cancer cells that overexpress c-Myc, leading to increased fatty acid oxidation, and that inhibition of CPT1 reduced growth of Myc-driven triple-negative breast cancer tumors [277]. The gene discussed is CPT1A; the disease is triple-negative breast carcinoma.